Advertisement

Index by author

March 01, 1994; Volume 22,Issue 2

  1. Raberger, G

    1. NG-nitro-L-arginine is not involved in enterohepatic cycling in rats.
      V K Piotrovskij, Z Kállay, J Horecký, T Trnovec, G Raberger and K Krejcy
      Drug Metabolism and Disposition March 1994, 22 (2) 338-339;

  2. Ramjit, H G

    1. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
      S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M Hoffman
      Drug Metabolism and Disposition March 1994, 22 (2) 200-205;

  3. Redza, Z M

    1. Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.
      P G Forkert, Z M Redza, S Mangos, S S Park and S P Tam
      Drug Metabolism and Disposition March 1994, 22 (2) 248-253;

  4. Regnier, B

    1. Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.
      L Dalgaard, R K Hjortkjaer, B Regnier and L Nordholm
      Drug Metabolism and Disposition March 1994, 22 (2) 289-293;

  5. Ridley, W P

    1. Milacemide metabolism in rat liver and brain slices by solids NMR.
      J R Garbow, W P Ridley, V Bork, Y Pan and J Schaefer
      Drug Metabolism and Disposition March 1994, 22 (2) 298-303;

  6. Rooney, C S

    1. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
      S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M Hoffman
      Drug Metabolism and Disposition March 1994, 22 (2) 200-205;

  7. Ross, D

    1. Solvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.
      X Cheng, C Maniglier-Poulet, D Ross and J A Ruth
      Drug Metabolism and Disposition March 1994, 22 (2) 206-210;

  8. Rubio, F

    1. Disposition of [14C]acitretin in humans following oral administration.
      F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C Town
      Drug Metabolism and Disposition March 1994, 22 (2) 211-215;

  9. Ruth, J A

    1. Solvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.
      X Cheng, C Maniglier-Poulet, D Ross and J A Ruth
      Drug Metabolism and Disposition March 1994, 22 (2) 206-210;
Back to top

In this issue

Advertisement